ArticleFrontiers in psychiatry2025
Unveiling psychobiological correlates in primary Sjögren's syndrome: a machine learning approach to determinants of disease burden.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Besides primary Sjögren's syndrome (pSS) is generally assessed through biological markers, growing evidence suggests that psychological and social factors-such as anxiety, depression, personality traits, and social support-may also play a role in disease burden. Relative contribution of these biopsychosocial dimensions to disease activity in pSS, however, has not been quantitatively compared. This study aimed to evaluate the predictive weight of different factors in determining both objective and subjective disease burden using machine learning (ML) models. Methods: 117 pSS patients, whose biological (blood cell counts, complement activity, IgG, RF, SSA, SSB), psychological (personality traits, depression, anxiety, basic self-esteem assessed via self-reported questionnaires), and social (socioeconomic status and social support) measures were collected in a composite database. Outcome variables were SSA/SSB autoantibodies and EULAR Sjögren Syndrome Patient Reported Index (ESSPRI), as indicators of biological and perceived disease burden, respectively. Three machine learning algorithms were trained to predict outcome variables, first by each measure category, then on the entire set of predictor variables. Permutation feature importance was used to assess the importance of the predictors. The five most important predictors were selected for all target outcomes. Results: Concerning autoantibodies, the model performed best with biological input only, in the case of ESSPRI, the complete dataset gave the best performance. Trait anxiety was selected as important negative predictor of both autoantibodies. Besides, biological measures (IgG, RF, platelet count) and age were among the five most important features. State anxiety and temperament trait 'Fatigability' were important positive predictors of ESSPRI, while character trait 'Pure-hearted conscience', IgG and RF were important negative predictors. Conclusions: Unexpected psychobiological correlations, like trait anxiety and IgG/RF as negative predictors of autoantibodies and ESSPRI, respectively, suggest different (immunobiological and psychosomatic) disease mechanisms and symptom burden. Importance of psychological factors in estimating disease burden may pave the way toward novel, more sensitive diagnostic tools and therapeutic methods and better understanding of pathomechanisms of pSS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.